DXC (DXC) Q4 2026 Earnings Call Transcript

DXC reported Q4 revenue of $3.1 billion, down 6.6% year over year and about $75 million below organic guidance, while adjusted EBIT margin of 7.6% and non-GAAP EPS of $0.77 came in at or slightly above expectations. Fiscal 2027 guidance calls for organic revenue to decline 3%-5%, adjusted EBIT margin to fall to 6%-7%, and EPS to decline to $2.40-$2.90, partly offset by $250 million of planned share repurchases. Management highlighted rapid AI adoption, the launch of OASIS with 10 customers, and a shift toward outcome-based revenue models, but near-term demand remains pressured by discretionary spending and weaker bookings.

Analysis

DXC is not trading like a clean turnaround; it is trading like a legacy services company where AI is simultaneously the remedy and the threat. The key second-order effect is that management’s 80% outcome-based mix makes AI-driven productivity more monetizable than in a pure time-and-materials model, but it also means the company is more exposed to pricing scrutiny if customers start demanding the savings upfront. That sets up a lag: internal AI adoption can support margins before revenue inflects, but the market will likely want proof that productivity gains are being translated into win-rate improvement, not just cost takeout.

The bigger competitive signal is that DXC is getting to final rounds on large deals but losing on capability specificity, which is usually a fixable go-to-market issue rather than a structural demand problem. That favors larger horizontal IT services peers and niche specialists with clearer vertical credibility, because customers appear to be using AI as a reason to reassess incumbents’ operating model, not just their price. If DXC’s new platforms like OASIS gain traction, the beneficiaries may actually be software-like valuation re-ratings at the company level, but near term the more likely effect is margin defense rather than top-line acceleration.

The stock’s setup is asymmetric over the next 1-2 quarters: guidance leaves room for further downside if project-based discretionary spend worsens, while the second-half improvement hinges on backlog wrap rather than a real demand reacceleration. That makes the near-term catalyst path weak unless Investor Day converts the AI story into measurable pipeline conversion, attach rates, or recurring revenue disclosure. Contrarian takeaway: the market may be underestimating how much operating leverage can still be extracted from the installed base, but it is probably not overestimating the cyclicality risk in GIS/CES yet.

Key Decisions for Investors

• Short DXC into the next 4-8 weeks on strength; use any post-guidance / pre-Investor Day rally to fade, targeting the view that the first-half revenue trough is still ahead. Risk/reward: favorable if project softness persists, stop on a sustained break above recent highs after Investor Day.
• Pair trade: long IT services with stronger execution visibility (e.g., ACN) vs short DXC for 1-3 months. Thesis: AI is a common theme, but execution quality and vertical credibility should command the premium.
• Buy a small starter long in DXC only via call spreads after Investor Day if management quantifies OASIS attach rates or recurring revenue conversion; risk/reward improves only if AI moves from narrative to bookings.
• For event-driven traders, consider DXC put spreads expiring after Q1 earnings as a defined-risk way to express downside to the 6.5%-7.5% organic decline guide. The trade works if management’s conservative guide proves not conservative enough.